Anna Mielech

Anna Mielech, PhD, is a regulatory affairs expert with extensive experience in in vitro diagnostics (IVD) medical devices. They currently serve as a Regulatory Affairs Principal at Cepheid and previously worked at the FDA as a Regulatory Expert and Microbiologist, where they led teams in reviewing emergency use authorization submissions during the COVID-19 pandemic. Anna has also held positions as a postdoctoral researcher at both Loyola University Chicago and Gdansk University of Technology, focusing on microbiology and antiviral drug development. They earned a PhD in Microbiology and Immunology from Loyola University Chicago and a Master's in Molecular and Pharmaceutical Biotechnology from Gdansk University of Technology.